Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.90p
   
  • Change Today:
    -0.14p
  • 52 Week High: 3.42
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 1,925,128
  • Market Cap: £7.91m
  • RiskGrade: 328

Tuesday broker round-up

By Caoimhe Toman

Date: Thursday 25 Jan 2018

LONDON (ShareCast) - (ShareCast News) - Countrywide: Berenberg upgrades to hold with a target price of 95p.
TBC Bank: Berenberg reiterates buy with a target price of 1,950p.

Bank of Georgia: Berenberg reiterates hold with a target price of 3,900p.

Glencore: Barclays reiterates overweight with a target price of 450p.

IG Group: Barclays reiterates overweight with a target price of 955p.

Paragon: Barclays reiterates equal weight with a target price of 490p.

Easyjet: Deutsche Bank reiterates hold with a target price of 1560p.

Sage: Shore Capital Markets reiterates buy.

Sainsbury: Shore Capital Markets reiterates buy.

Crest Nicholson: Shore Capital Markets reiterates buy.

JD Witherspoon: Shore Capital Markets reiterates buy.

Cairn Energy: Canaccord reiterates buy with a target price of 260p.

SSP Group plc: Canaccord reiterates sell with a target price of 570p.

Immupharma: Northland Capital Markets reiterates buy with a target price of 181p.

Alexander Mining: Northland Capital Markets reiterates corporate.

Topp tiles plc: Berenberg reiterates hold with a target price of 80p.

XL Media plc: Berenberg reiterates buy with a target price of 290p.

Staffline Group plc: Berenberg reiterates buy with a target price of 1.250p.

Antofagasta plc: Berenberg reiterates sell with a tp of 750p.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.90p
Change Today -0.14p
% Change -6.86 %
52 Week High 3.42
52 Week Low 0.85
Volume 1,925,128
Shares Issued 416.44m
Market Cap £7.91m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.34% below the market average62.34% below the market average62.34% below the market average62.34% below the market average62.34% below the market average
9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average
Price Trend
44.24% below the market average44.24% below the market average44.24% below the market average44.24% below the market average44.24% below the market average
12.73% above the sector average12.73% above the sector average12.73% above the sector average12.73% above the sector average12.73% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:28 419,759 @ 2.00p
16:29 20,000 @ 2.00p
16:29 47,619 @ 2.01p
16:28 69,550 @ 2.00p
16:28 250,000 @ 2.00p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page